1. Home
  2. RCUS vs YEXT Comparison

RCUS vs YEXT Comparison

Compare RCUS & YEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • YEXT
  • Stock Information
  • Founded
  • RCUS 2015
  • YEXT 2006
  • Country
  • RCUS United States
  • YEXT United States
  • Employees
  • RCUS N/A
  • YEXT N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • YEXT EDP Services
  • Sector
  • RCUS Health Care
  • YEXT Technology
  • Exchange
  • RCUS Nasdaq
  • YEXT Nasdaq
  • Market Cap
  • RCUS 1.2B
  • YEXT 1.0B
  • IPO Year
  • RCUS 2018
  • YEXT 2017
  • Fundamental
  • Price
  • RCUS $12.03
  • YEXT $8.77
  • Analyst Decision
  • RCUS Buy
  • YEXT Strong Buy
  • Analyst Count
  • RCUS 8
  • YEXT 4
  • Target Price
  • RCUS $20.71
  • YEXT $9.44
  • AVG Volume (30 Days)
  • RCUS 711.9K
  • YEXT 1.2M
  • Earning Date
  • RCUS 11-05-2025
  • YEXT 09-08-2025
  • Dividend Yield
  • RCUS N/A
  • YEXT N/A
  • EPS Growth
  • RCUS N/A
  • YEXT N/A
  • EPS
  • RCUS N/A
  • YEXT N/A
  • Revenue
  • RCUS $262,000,000.00
  • YEXT $449,657,000.00
  • Revenue This Year
  • RCUS N/A
  • YEXT $8.92
  • Revenue Next Year
  • RCUS N/A
  • YEXT $5.14
  • P/E Ratio
  • RCUS N/A
  • YEXT $145.54
  • Revenue Growth
  • RCUS 6.07
  • YEXT 13.51
  • 52 Week Low
  • RCUS $6.50
  • YEXT $5.51
  • 52 Week High
  • RCUS $18.98
  • YEXT $9.20
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 66.27
  • YEXT 52.48
  • Support Level
  • RCUS $11.30
  • YEXT $8.62
  • Resistance Level
  • RCUS $12.05
  • YEXT $8.91
  • Average True Range (ATR)
  • RCUS 0.58
  • YEXT 0.21
  • MACD
  • RCUS 0.02
  • YEXT -0.05
  • Stochastic Oscillator
  • RCUS 81.30
  • YEXT 44.23

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

Share on Social Networks: